Polycystic Ovary Syndrome: A Review of Management Outcomes in a Low Resource Setting

Polycystic Ovary Syndrome: A Review of Management Outcomes in a Low Resource Setting Polycystic Ovary Syndrome (PCOS) is the most common endocrinopathy of women within the reproductive age affecting about 6-8% of this age group. It is a heterogeneous collection of signs and symptoms that together form a spectrum of disorders with mild presentation in some, while in others presents with severe disturbance of reproductive, endocrine and metabolic functions.

[1]  Julie Brown,et al.  Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. , 2012, The Cochrane database of systematic reviews.

[2]  A. Balen.  Polycystic Ovary Syndrome and Secondary Amenorrhoea , 2012, Dewhurst's Textbook of Obstetrics & Gynaecology.

[3]  A. Moini,et al.  A possible role for familial thrombophilia in women with polycystic ovarian syndrome , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  D. Glintborg,et al.  Thiazolinedione treatment in PCOS – an update , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[5]  S. Cavkaytar,et al.  Cardiovascular risk factors in polycystic ovary syndrome , 2010, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[6]  D. Glintborg,et al.  An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  R. Shayya,et al.  Reproductive endocrinology of adolescent polycystic ovary syndrome , 2010, BJOG : an international journal of obstetrics and gynaecology.

[8]  R. Norman,et al.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. , 2009, Fertility and sterility.

[9]  A. Balen.  Surgical treatment of polycystic ovary syndrome. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[10]  R. Azziz,et al.  Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  F. Manguso,et al.  Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[12]  Didier Dewailly,et al.  Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.

[13]  R. Norman,et al.  Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. , 2003, The Cochrane database of systematic reviews.

[14]  A. Balen.  Ovulation induction — Optimizing results and minimizing risks , 2003, Human fertility.

[15]  A. Duleba,et al.  Optimizing ovulation induction in women with polycystic ovary syndrome , 2002, Current opinion in obstetrics & gynecology.

[16]  R. Barbieri,et al.  Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. , 2000, American journal of obstetrics and gynecology.

[17]  A. Balen,et al.  Polycystic ovary syndrome: a risk factor for cardiovascular disease? , 2000, BJOG : an international journal of obstetrics and gynaecology.

[18]  R. Legro.  Polycystic ovary syndrome. Phenotype to genotype. , 1999, Endocrinology and metabolism clinics of North America.

[19]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[20]  J. Ikechebelu,et al.  Reproductive outcome in infertile women with clomiphene citrate resistant polycystic ovarian syndrome treated by laparoscopic ovarian drilling , 2010 .

[21]  A. Orhue,et al.  The prevalence and risk factors of abnormal glucose tolerance amongst Nigerian women with polycystic ovary syndrome , 2010 .